课题基金 / 基金详情

SAGEs: Self-assembled peptide-based cages for the presentation, encapsulation and delivery of bioactive molecules to cells in culture

SAGEs: Self-assembled peptide-based cages for the presentation, encapsulation and delivery of bioactive molecules to cells in culture
SAGE:基于肽的自组装笼,用于将生物活性分子呈现、封装和递送至培养中的细胞
批准号:
BB/L010518/1
负责人:
Dek Woolfson
金额:
$93.22万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Dek Woolfson的其他基金

相似基金

相关文献

中文摘要
翻译
研究背景:将生物活性分子(药物、DNA和蛋白质)输送到实验室或人体内的特定细胞的能力将对生物学和医学的许多分支产生影响。想象一下,能够有选择地找到并摧毁患病细胞;或者在动物和人体试验之前,“简单地”在一系列细胞内测试一种新药的有效性?不幸的是,对于这个在细胞内传递生物活性分子的问题,没有通用的解决方案,即使是定制的真正的解决方案也很少。这个问题并不简单,生物学如何进化病毒来做到这一点就是最好的例证。病毒是令人震惊的自然纳米级包,通常被称为病毒粒子。尽管它们有多种类型,但所有的病毒粒子都有三种功能:(1)它们通常识别特定的细胞类型,这是通过在它们的表面呈现分子来识别目标细胞上的分子来实现的;(2)它们穿透细胞的外部屏障;(3)它们传递有效载荷,这是在宿主细胞中制造更多病毒的遗传信息。功能(1)和(2)由病毒外壳或衣壳执行。不足为奇的是,许多人试图模仿这些结构来传递RNA和DNA以外的有效载荷。这项研究的目的、目标和抱负:拟议工作的总体雄心是生产出直径约为人类头发宽度的百分之一的中空笼状颗粒,即所谓的鼠尾草颗粒。我们将以一种模块化的方式完成这项工作,使用称为多肽的蛋白质的小版本。每个多肽模块将具有特定的功能,以模拟病毒粒子的属性:一组将用于识别特定的细胞类型;另一组将用于构建粒子的外壳;第三组将携带具有生物活性的有效载荷。仅凭这些模块本身就没有任何用处。然而,如果正确结合,它们可以组装成类似病毒的颗粒,但如果没有(致命的)RNA和DNA货物,它们将含有药物或有用的蛋白质。为了做到这一点,我们将建立一个由化学家、生化学家、细胞生物学家和分子模型师组成的多学科团队,这些团队已经交付了鼠尾草颗粒。物理学家将共同设计和制造分子的组件,然后与生物学家合作测试和可视化它们如何与细胞相互作用并提供有效载荷。潜在的应用和好处:在整个研究过程中,我们将与Synaxin公司合作,该公司对靶向和杀死体内特定类型的疾病细胞感兴趣。除了提供试剂和技术诀窍外,这种伙伴关系还将鼓励现实生活中的应用,从而为我们的研究提供明确和实际的终点。通过这种方式,我们将探索SAGE组装和工程的基本原理,以及功能SAGE在细胞生物学和医学中的潜在应用。广义地说,这种构建复杂生物分子、组装和系统的模块化和系统化的方法被称为合成生物学。合成生物学的目的和精神是使生物系统的工程变得更容易(即系统、快速和可预测),并最终制造出有用的功能和产品。例如,合成生物学正被认为在生产新药、生物燃料和精细化学品方面越来越重要。它是由政府和研究委员会投资的,目的是充分发展该领域,使英国(生物技术)产业和经济直接受益。我们提案的一个关键方面是它符合这种精神和这些愿望:我们的目标是为上述三种特性中的每一种制作一个由不同模块组成的工具包;通过这种方式,模块可以快速、可靠地结合在一起,并具有可预测的结果,以生成不同的粒子,用于靶向和处理不同的细胞和疾病。
英文摘要
CONTEXT OF THE RESEARCH: An ability to deliver biologically active molecules (drugs, DNA and proteins) to specified cells either in the lab or the body would impact on many branches of biology and medicine. Imagine being able to selectively find and destroy diseased cells; or "simply" to test the effectiveness of a new drug inside a range of cells before animal and human trials? Unfortunately, there is no general solution to this problem of delivering bioactive molecules within cells, and even bespoke true solutions are few and far between. The problem is not straightforward, and is best illustrated by how biology has evolved viruses to do this.Viruses are astonishing natural nanoscale packages, usually termed virions. Though they come in many types, all virions perform three functions: (1) they recognise often specific cell types, which they do by presenting molecules on their surfaces to recognize molecules on the target cells; (2) they penetrate the outer barriers of the cell; and (3) they deliver a payload, which is the genetic information to make more virus in the host cell. Functions (1) and (2) are performed by the viral coats, or capsids. Not surprisingly, many people have tried to mimic these structures to deliver payloads other than RNA and DNA. AIMS, OBJECTIVES AND ASPIRATIONS OF THE RESEARCH: The overall ambition of the proposed work is to produce hollow, cage-like particles that have the diameter of about one hundredth the width of a human hair, so-called SAGE particles. We will do this in a modular way, using small versions of proteins called peptides. Each peptide module will have a specific function to mimic one the properties of virions: one set will be made to recognize specific cell types; another will be used to construct the casing of the particles; and the third set will carry the biologically active payloads. On their own, these modules would not be useful at all. However, if combined correctly they could assemble into virus-like particles, but without the (deadly) RNA and DNA cargo, instead they would contain drugs or useful proteins.To do this we will build on a multidisciplinary team of chemists, biochemists, cell biologists and molecular modellers that has delivered the SAGE particles. The physical scientists will work together to design and make the assemblies of molecules, and then work with the biologists to test and visualise how they interact with cells and deliver their payloads.POTENTIAL APPLICATIONS AND BENEFITS: Throughout the research, we will work with a company, Syntaxin, interested in targeting and killing particular diseased cell types in the body. As well as providing reagents and know-how, this partnership will encourage real-life applications, and thus clear and practical end points for our research. In this way, we will explore both the fundamentals of SAGE assembly and engineering, and potential applications of functional SAGEs in cell biology and medicine.Broadly speaking, this modular and systematic approach to constructing complex biological molecules, assemblies and systems is called "synthetic biology". The aim and spirit of synthetic biology is to make the engineering of biological systems easier (that is, systematic, quick, and predictable) and ultimately to make useful functions and products. For example, synthetic biology is being recognised as increasingly important to generate new medicines, biofuels and fine chemicals. It is being invested in by Government and Research Councils, with the aim of developing the field sufficiently to be of direct benefit to the UK (biotech) industry and economy. One of the key aspects of our proposal is that it fits with this spirit and these aspirations: we aim to make a toolkit of different modules for each of the above three properties; in this way, modules could be combined rapidly, reliably and with predictable outcomes to generate different particles for targeting and tackling different cells and diseases.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acsnano.7b07785
发表时间: 2018-02-27
期刊: ACS nano
影响因子: 17.1
作者: [Galloway JM, Senior L, Fletcher JM, Beesley JL, Hodgson LR, Harniman RL, Mantell JM, Coombs J, Rhys GG, Xue WF, Mosayebi M, Linden N, Liverpool TB, Curnow P, Verkade P, Woolfson DN]
通讯作者: Woolfson DN
DOI: 10.1039/d0sc02593c
发表时间: 2020-07-08
期刊: Chemical science
影响因子: 8.4
作者: [Street STG, He Y, Jin XH, Hodgson L, Verkade P, Manners I]
通讯作者: Manners I
BrisEngBio: From Synthetic to Engineering Biology at Bristol
  • 批准号:
    BB/W013959/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $193.41万
  • 财政年份:
    2022
  • 负责人:
    Dek Woolfson
  • 依托单位:
Coiled-coil Technology for Regulating Intracellular Protein-protein Interactions
  • 批准号:
    BB/V006231/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.09万
  • 财政年份:
    2021
  • 负责人:
    Dek Woolfson
  • 依托单位:
19-BBSRC-NSF/BIO. Leveraging synthetic biology to probe the rules of cell morphogenesis.
  • 批准号:
    BB/V004220/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $102.64万
  • 财政年份:
    2021
  • 负责人:
    Dek Woolfson
  • 依托单位:
CuPiD: A European Network in Computational Protein Design
  • 批准号:
    BB/T020105/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $3.9万
  • 财政年份:
    2021
  • 负责人:
    Dek Woolfson
  • 依托单位:
国内基金
海外基金
Self-DNA介导的CD4+组织驻留记忆T细胞(Trm)分化异常在狼疮肾炎发病中的作用及机制研究
  • 批准号:
    82371813
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    熊思东
  • 依托单位:
基于受体识别和转运整合的self-DNA诱导采后桃果实抗病反应的机理研究
  • 批准号:
    32302161
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    黎春红
  • 依托单位:
基于广义测量的多体量子态self-test的实验研究
  • 批准号:
    12104186
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    边志浩
  • 依托单位:
Self-shrinkers的刚性及相关问题
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    魏国新
  • 依托单位: